| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |